Vice President of Business, Operations and Finance
United States of America
Rick Lundberg has 25 years of strategic, operational and commercial experience in the life sciences industry that ranges from de novo ventures to leading global biopharmaceutical companies. Mr. Lundberg has been closely involved with Navitor since its initial seed funding, with overall responsibility for all business aspects of the company. Prior to joining Navitor, Mr. Lundberg founded 7S BioVentures, which provided business development and corporate strategy advisory services to emerging life sciences companies. From 2006 to 2009, he was responsible for ex-U.S. commercial strategy and business development at Targanta Therapeutics. Previously, Mr. Lundberg led therapeutics business development initiatives and managed the genomics services business at Celera Genomics. He began his career at Biogen, where he served for nearly a decade in a broad range of business roles, including business development, program management, investor relations, sales and marketing. Mr. Lundberg holds a BA in Biochemical Sciences from Harvard University.